FDA IND Received for Gene Therapy for the Treatment of Retinitis Pigmentosa
SparingVision is a biotechnology company focused on the discovery [...]
SparingVision is a biotechnology company focused on the discovery [...]
One of the four human sight-restoring technologies featured in [...]
Avista Therapeutics, which recently launched as a spinout of [...]
In his lab, McGowan Institute for Regenerative Medicine affiliated faculty [...]
People with congenital stationary night blindness (CSNB) are unable to [...]
For up to 3 million Americans each year, what was [...]
A novel computational platform developed by researchers from the University [...]
Allison Proffitt, for Bio-IT World, recently reported how innovative vision [...]
For centuries, people thought that blindness was incurable – once [...]
After 40 years of blindness, a 58-year-old man can once [...]